Acid-Activated TAT Peptide-Modified Biomimetic Boron Nitride Nanoparticles for Enhanced Targeted Codelivery of Doxorubicin and Indocyanine Green: A Synergistic Cancer Photothermal and Chemotherapeutic Approach.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Acid-Activated TAT Peptide-Modified Biomimetic Boron Nitride Nanoparticles for Enhanced Targeted Codelivery of Doxorubicin and Indocyanine Green: A Synergistic Cancer Photothermal and Chemotherapeutic Approach.
- Published In:
- ACS applied materials & interfaces, 16(19), 25101-25112 (2024)
- Authors:
- Li, Hui(3), Fan, Yuan, Shen, Yizhe, Xu, Huashan, Zhang, Huijie, Chen, Fuxue, Feng, Shini
- Database ID:
- RPEP-08667
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08667APA
Li, Hui; Fan, Yuan; Shen, Yizhe; Xu, Huashan; Zhang, Huijie; Chen, Fuxue; Feng, Shini. (2024). Acid-Activated TAT Peptide-Modified Biomimetic Boron Nitride Nanoparticles for Enhanced Targeted Codelivery of Doxorubicin and Indocyanine Green: A Synergistic Cancer Photothermal and Chemotherapeutic Approach.. ACS applied materials & interfaces, 16(19), 25101-25112. https://doi.org/10.1021/acsami.4c01622
MLA
Li, Hui, et al. "Acid-Activated TAT Peptide-Modified Biomimetic Boron Nitride Nanoparticles for Enhanced Targeted Codelivery of Doxorubicin and Indocyanine Green: A Synergistic Cancer Photothermal and Chemotherapeutic Approach.." ACS applied materials & interfaces, 2024. https://doi.org/10.1021/acsami.4c01622
RethinkPeptides
RethinkPeptides Research Database. "Acid-Activated TAT Peptide-Modified Biomimetic Boron Nitride..." RPEP-08667. Retrieved from https://rethinkpeptides.com/research/li-2024-acidactivated-tat-peptidemodified-biomimetic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.